Form 4: DocuSign CRO Sells 6,000 Shares via 10b5-1 Plan
Insider Transaction Report
DocuSign's Chief Revenue Officer, Paula Hansen, sold 6,000 shares of common stock on January 2, 2026, through a pre-arranged 10b5-1 plan.
Summary
- Paula Hansen, Chief Revenue Officer of DocuSign, Inc. (DOCU), reported the sale of 6,000 shares of the company's common stock.
- The transactions occurred on January 2, 2026, and were executed pursuant to a Rule 10b5-1 plan.
- The shares were sold in four separate blocks at weighted average prices ranging from $65.43 to $68.62 per share.
- Specifically, 1,290 shares were sold at an average price of $65.43, 2,613 shares at $66.94, 1,100 shares at $67.78, and 997 shares at $68.62.
- Following these sales, Hansen beneficially owns 68,970 shares of DocuSign common stock directly.
Sentiment
Score: 5
Explanation: The sale of shares by an executive, particularly when conducted under a pre-arranged 10b5-1 plan, is a routine event often related to personal financial planning and does not inherently signal a positive or negative outlook for the company.
Positives
- The transactions were conducted under a Rule 10b5-1 plan, which indicates pre-scheduled sales and helps mitigate concerns about opportunistic insider trading.
Negatives
- An officer selling shares reduces their direct equity stake in the company.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction report is specific to DocuSign and its Chief Revenue Officer and does not directly provide broader industry trends or competitive insights.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The reported transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, which is a mechanism designed to allow insiders to sell shares without being accused of trading on material non-public information. | 01/02/2026 | This demonstrates adherence to corporate governance best practices regarding insider trading, providing transparency and reducing potential concerns about the timing of the sales. |
Stakeholder Impact
- Shareholders: The sale by a key executive could be perceived neutrally to slightly negatively, though the 10b5-1 plan mitigates concerns about opportunistic selling. It represents a minor reduction in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of earliest transaction (sale of common stock by Paula Hansen). |
| 01/06/2026 | Date the Form 4 was signed by Derrick Chapman, Attorney-in-fact for Paula Hansen. |
Recommendation
holdThis Form 4 filing details a routine insider stock sale executed under a pre-arranged 10b5-1 plan. Such transactions are typically for personal financial management and do not provide significant new information to alter an investment thesis for DocuSign. Investors should continue to evaluate the company based on its fundamental performance, market position, and broader financial reports rather than this single insider transaction.
Keywords
DocuSign, DOCU, insider transaction, Form 4, stock sale, 10b5-1 plan, Paula Hansen, Chief Revenue Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.